Phreesia, Inc. (NYSE:PHR) Director Sells $12,852.60 in Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) Director Lisa Egbuonu-Davis sold 465 shares of the business's stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $27.64, for a total transaction of $12,852.60. Following the sale, the director directly owned 21,572 shares in the company, valued at approximately $596,250.08. This represents a 2.11% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Lisa Egbuonu-Davis also recently made the following trade(s):

• On Thursday, June 26th, Lisa Egbuonu-Davis sold 2,802 shares of Phreesia stock. The stock was sold at an average price of $27.67, for a total transaction of $77,531.34.

Phreesia Trading Up 2.7%

Shares of NYSE:PHR traded up $0.68 during trading on Monday, reaching $26.16. 88,221 shares of the stock were exchanged, compared to its average volume of 454,447. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The firm has a market cap of $1.56 billion, a price-to-earnings ratio of -35.27 and a beta of 0.72. The firm's 50-day moving average price is $26.50 and its 200 day moving average price is $26.41.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. The company had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The business's quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the firm posted ($0.05) earnings per share. On average, sell-side analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PHR has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. DA Davidson dropped their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. KeyCorp raised their target price on shares of Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Truist Financial raised their target price on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Finally, Citigroup restated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $32.27.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of PHR. Invesco Ltd. increased its holdings in Phreesia by 0.9% in the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock valued at $1,013,000 after buying an additional 357 shares during the last quarter. Diversified Trust Co increased its holdings in Phreesia by 1.0% in the second quarter. Diversified Trust Co now owns 45,042 shares of the company's stock valued at $1,282,000 after buying an additional 426 shares during the last quarter. NewEdge Advisors LLC increased its holdings in Phreesia by 12.1% in the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after buying an additional 459 shares during the last quarter. Arcadia Investment Management Corp MI increased its holdings in Phreesia by 0.7% in the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock valued at $2,371,000 after buying an additional 615 shares during the last quarter. Finally, QRG Capital Management Inc. increased its holdings in Phreesia by 8.0% in the first quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock valued at $284,000 after buying an additional 827 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.